Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Vilanterol trifenatate (substance) |
Is a |
False |
Vilanterol (substance) |
Inferred relationship |
Some |
|
Product containing fluticasone and vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Product containing fluticasone and vilanterol in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vilanterol (substance) |
Inferred relationship |
Some |
|
Product containing vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
1 |
Product containing fluticasone and umeclidinium and vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Product containing fluticasone and umeclidinium and vilanterol in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vilanterol (substance) |
Inferred relationship |
Some |
|
Fluticasone- and umeclidinium- and vilanterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone- and vilanterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Vilanterol trifenatate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
|
Product containing only vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
1 |
Product containing only fluticasone and umeclidinium and vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone and vilanterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone and vilanterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |
Fluticasone and umeclidinium and vilanterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Vilanterol (substance) |
Inferred relationship |
Some |
2 |